U.S. Markets closed

Medical Developments International Limited (MVP.AX)

ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
5.150.00 (0.00%)
At close: 4:10PM AEST

Medical Developments International Limited

4 Caribbean Drive
Scoresby, VIC 3179
61 3 9547 1888

IndustryDrug Manufacturers - Major
Full Time Employees42

Key Executives

Mr. John Stewart Sharman M.App.Fin, CA, B EcChief Exec. Officer361.4kN/A51
Mr. Mark Edwards BAcc, CAGroup Financial Controller and Company Sec.164.81kN/AN/A
Dr. Scott CourtneyDirector of Research & OperationsN/AN/AN/A
Keith JeffsGen. Mang. of Sales & MarketingN/AN/AN/A
Maggie OhDirector of Scientific AffairsN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Medical Developments International Limited manufactures and distributes pharmaceutical drugs, and medical and veterinary equipment in Australia, New Zealand, Europe, North America, the Middle East, Asia, and South Africa. It operates through three segments: Pharmaceuticals, Medical Devices, and Veterinary products. The company offers Penthrox for emergency or procedural pain relief. It also provides asthma and COPD medication devices, as well as a range of masks and peak flow meters for complete asthma management. In addition, the company offers medical devices; and various veterinary anesthetic machines to veterinarians. Medical Developments International Limited is headquartered in Scoresby, Australia.

Corporate Governance

Medical Developments International Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.